Document is current
Any future updates will be listed below
-
Authors
Wang, Yujia https://orcid.org/0000-0002-7099-6283
Dix, Melissa M.
Bianco, Giulia
Remsberg, Jarrett R. https://orcid.org/0000-0002-5234-0168
Lee, Hsin-Yu
Kalocsay, Marian
Gygi, Steven P.
Forli, Stefano https://orcid.org/0000-0002-5964-7111
Vite, Gregory
Lawrence, R. Michael
Parker, Christopher G. https://orcid.org/0000-0001-8509-9289
Cravatt, Benjamin F. https://orcid.org/0000-0001-5330-3492
- License Information
-
More Information
Article History
Received: 27 February 2019
Accepted: 10 September 2019
First Online: 28 October 2019
Competing interests
: The authors declare competing financial interests. B.F.C. is a founder and advisor to Vividion Therapeutics, a biotechnology company interested in using chemical proteomic methods to develop small-molecule drugs to treat human disease. C.G.P. serves as a consultant for Vividion Therapeutics.
